# Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

> **NCT06890429** · PHASE2 · COMPLETED · sponsor: **Research Institute of Influenza, Russia** · enrollment: 120 (actual)

## Conditions studied

- Respiratory Synctial Virus Infections

## Interventions

- **BIOLOGICAL:** RSV/Flu-01E
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06890429
- **Lead sponsor:** Research Institute of Influenza, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-07
- **Primary completion:** 2024-01-08
- **Final completion:** 2024-04-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06890429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06890429, "Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06890429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*